Bank of America’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,317
Closed -$85K 8896
2021
Q4
$85K Sell
5,317
-4,966
-48% -$99.4K ﹤0.01% 6957
2021
Q3
$206K Sell
10,283
-3,119
-23% -$80.5K ﹤0.01% 6295
2021
Q2
$414K Hold
13,402
﹤0.01% 5573
2021
Q1
$344K Sell
13,402
-3,818
-22% -$95.7K ﹤0.01% 5657
2020
Q4
$276K Hold
17,220
﹤0.01% 5388
2020
Q3
$210K Buy
+17,220
New +$249K ﹤0.01% 5271

Other funds holding RNLX

Bank of America's RNLX Position: Q1 2022 in Review

Bank of America sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2022, closing a stake of 5,317 shares — an estimated $85K sold.

Bank of America first reported a position in RNLX in Q3 2020 and held it in 6 quarters. The position peaked at $414K in Q2 2021. 35 funds tracked by Wall St. Rank hold RNLX as of Q1 2022.

  • Bank of America reported no remaining Renalytix plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 5,317 Renalytix plc American Depositary Shares shares in Q1 2022, an estimated $85K.
  • Bank of America first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 6 quarters.
  • Bank of America's Renalytix plc American Depositary Shares position peaked at $414K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.